New IP guidance promises to transform the NHS. Will it deliver?

The move could unlock billions in life sciences collaborations and position the UK to rival the US and China. But turning a famously conservative, patient-safety-first institution into a commercially savvy innovation hub will be no small feat.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

NHS updates outdated IP rules in bid to revive UK life sciences

20 November 2025 The country’s public health service has replaced its IP framework with a nine-step plan, as the government tries to reposition the UK as a global life sciences leader.

Europe

As investment in UK life sciences wanes, is the sector in trouble?

14 October 2025 As Big Pharma stalls investment in the UK, the government urgently needs to return to the negotiating table to salvage a key growth area, writes Tim Belcher of EIP.

Europe

UK govt sets sights on being AI drug discovery ‘world leader’

13 June 2025 Government unveils £8M OpenBind consortium to lead in AI drug discovery | Project to build world’s largest drug–protein dataset | Backed by new Sovereign AI Unit, Consortium will be based at national synchrotron facility in Oxfordshire.

More features

WATCH: Reshaping the rules—recent IP reforms and their impact on Brazil’s pharma market

UPC draws hard line on urgency in first SPC dispute

Patent and SPC litigator makes the move from Carpmaels

EU Pharma Package hits the final stretch—but can negotiators agree?

UPC appeals court hands Amgen a win in cholesterol dispute

Squires affirms USPTO’s stance on AI with revised guidance

UPC judges call for greater female advocacy at court

The clinical trial dilemma: Navigating European practice

New IP guidance promises to transform the NHS. Will it deliver?

More on this story

Editor's picks

Editor's picks

More features